Light-activated gene transduction enhances adeno-associated virus vector-mediated gene expression in human articular chondrocytes

Arthritis and Rheumatism

Volumn 46, Issue 8, 2002, Pages 2095-2104

  Ulrich Vinther, Michael ^a,b   Maloney, Michael D ^a   Goater, J Jeffrey ^a   Søballe, Kjeld ^b   Goldring, Mary B ^a,c   O'Keefe, Regis J ^a   Schwarz, Edward M ^a,c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c NEW ENGLAND BAPTIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN;

ARTHRITIS; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL IMMORTALIZATION; CELL SELECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FLUORESCENCE; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; THICKNESS; TOXICITY; ULTRAVIOLET RADIATION; VIRUS RECOMBINANT;

ADOLESCENT; ADULT; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; DEPENDOVIRUS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MALE; MIDDLE AGED; TRANSDUCTION, GENETIC; TRANSGENES; ULTRAVIOLET RAYS;

EID: 0036677129     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10433     Document Type: Article

References (52)

1. Management of osteochondral injuries of the knee
2. Surgical alternatives for treatment of articular cartilage lesions
3. Osteochondral mosaicplasty for the treatment of focal chondral and osteochondral lesions of the knee and talus in the athlete: Rationale, indications, techniques, and results
4. Treatment of osteochondral injuries: Genetic engineering
5. Degradation and repair of articular cartilage
6. Future directions for research and treatment of osteoarthritis
7. Overview of treatment options for arthritis in the active patient
8. Mechanisms of cartilage destruction and novel nonsurgical therapeutic strategies to retard cartilage injury in rheumatoid arthritis
9. Stem cells for repair of cartilage and bone: The next challenge in osteoarthritis and rheumatoid arthritis
10. Articular cartilage biology and regeneration
11. Cartilage substitutes: Overview of basic science and treatment options
12. Articular cartilage: Injuries and potential for healing
13. Effects of growth factors on cartilage repair
14. Using gene therapy to protect and restore cartilage
15. Rheumatoid arthritis
16. Gene therapy for rheumatic diseases
17. Gene therapy: Promises and problems
18. Gene therapy for rheumatoid arthritis
19. Gene therapy approaches for treating rheumatoid arthritis
20. Adeno-associated virus vectors for gene therapy: More pros than cons?
21. Building a better vector: The manipulation of AAV virions
22. Rescue of adeno-associated virus from recombinant plasmids: Gene correction within the terminal repeats of AAV
23. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication
24. The adeno-associated virus vector for orthopaedic gene therapy
25. Disease-inducible transgene expression from a recombinant adeno-associated virus vector in a rat arthritis model
26. Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist
27. Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis
28. Gene delivery to human chondrocytes by an adeno associated virus vector
29. Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis
30. Adeno-associated virus mediates long-term gene transfer and delivery of chondroprotective IL-4 to murine synovium
31. Adeno-associated virus production of soluble tumor necrosis factor receptor neutralizes tumor necrosis factor alpha and reduces arthritis
32. Recombinant adeno-associated virus for muscle directed gene therapy
33. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus
34. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector
35. Gene therapy of Parkinson's disease using adeno-associated virus (AAV) vectors
36. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
37. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
38. Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors
39. Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver
40. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus
41. Intracellular trafficking of adeno-associated virus vectors: Routing to the late endosomal compartment and proteasome degradation
42. Real-time single-molecule imaging of the infection pathway of an adeno-associated virus
43. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors
44. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis
45. Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors
46. Immortalized human adult articular chondrocytes maintain cartilage-specific phenotype and responses to interleukin-1β
47. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
48. Alpha Vbeta5 integrin: A co-receptor for adeno-associated virus type 2 infection
49. Regulation of the collagen II gene in vitro and in transgenic mice
50. A 182 bp fragment of the mouse pro alpha I(II) collagen gene is sufficient to direct chondrocyte expression in transgenic mice
51. The 2.2-kb promoter of cartilage-derived retinoic acid-sensitive protein controls gene expression in cartilage and embryonic mammary buds of transgenic mice
52. A pilot study of the effect of oral 8-methoxypsoralen and intraarticular ultraviolet light on rheumatoid synovitis